# Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults

> **NCT06039579** · PHASE2 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 44 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** VH4004280
- **DRUG:** VH4011499
- **DRUG:** VH4004280 Matching Placebo
- **DRUG:** VH4011499 Matching Placebo
- **DRUG:** Antiretroviral therapy

## Key facts

- **NCT ID:** NCT06039579
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-25
- **Primary completion:** 2024-06-24
- **Final completion:** 2024-06-24
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2025-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06039579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06039579, "Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06039579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*